Literature DB >> 19523650

Linking neuron and skin: matrix metalloproteinases in amyotrophic lateral sclerosis (ALS).

Lubin Fang1, Friederike Huber-Abel, Marko Teuchert, Corinna Hendrich, Johannes Dorst, Dagmar Schattauer, Heinz Zettlmeissel, Meinhard Wlaschek, Karin Scharffetter-Kochanek, Hayrettin Tumani, Albert C Ludolph, Johannes Brettschneider.   

Abstract

Amyotrophic lateral sclerosis (ALS) mainly affects the motor neurons but may also include other organs such as the skin. We aimed to determine whether matrix metalloproteinases could provide a link between neuronal degeneration and skin alterations in ALS. We measured CSF, serum and skin tissue MMP-2 and MMP-9 using ELISA and malondialdehyde (MDA), a marker of lipid peroxidation, using High Performance Liquid Chromatography (HPLC) in 54 ALS patients and 36 controls. We found CSF and skin MMP-9 to be elevated in ALS as compared to controls (p<0.001, p=0.03, respectively). We observed CSF MMP-9 to be highest in patients with a rapid progressive course of disease (p=0.008). In contrast, we found no significant differences of CSF, serum or skin concentrations of MMP-2 as compared to controls. CSF MMP-2 concentrations decreased with duration of disease (p=0.04, R=-0.31). MDA was elevated in serum of ALS (p<0.001), though no correlation with MMP-2 or MMP-9 was observed. Our findings indicate a general upregulation of MMP-9 in ALS. MMP-9 seems to play a role in both neurodegeneration and skin changes in ALS and could thus be a common factor linking otherwise distant aspects of disease pathology.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19523650     DOI: 10.1016/j.jns.2009.05.025

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  27 in total

1.  Stem cells and the modeling of the extracellular matrix--the library of cells needs suitable bookshelves.

Authors:  Stefan Lorenzl
Journal:  J Mol Med (Berl)       Date:  2010-06       Impact factor: 4.599

2.  Metalloproteinase alterations in the bone marrow of ALS patients.

Authors:  Patrizia Bossolasco; Lidia Cova; Cinzia Calzarossa; Federica Servida; Niccolò Emanuele Mencacci; Francesco Onida; Elio Polli; Giorgio Lambertenghi Deliliers; Vincenzo Silani
Journal:  J Mol Med (Berl)       Date:  2010-01-21       Impact factor: 4.599

Review 3.  The Roles of Matrix Metalloproteinases and Their Inhibitors in Human Diseases.

Authors:  Griselda A Cabral-Pacheco; Idalia Garza-Veloz; Claudia Castruita-De la Rosa; Jesús M Ramirez-Acuña; Braulio A Perez-Romero; Jesús F Guerrero-Rodriguez; Nadia Martinez-Avila; Margarita L Martinez-Fierro
Journal:  Int J Mol Sci       Date:  2020-12-20       Impact factor: 5.923

Review 4.  Metalloproteinases and their tissue inhibitors in Alzheimer's disease and other neurodegenerative disorders.

Authors:  Santiago Rivera; Laura García-González; Michel Khrestchatisky; Kévin Baranger
Journal:  Cell Mol Life Sci       Date:  2019-06-13       Impact factor: 9.261

Review 5.  Clinical perspective on oxidative stress in sporadic amyotrophic lateral sclerosis.

Authors:  Emanuele D'Amico; Pam Factor-Litvak; Regina M Santella; Hiroshi Mitsumoto
Journal:  Free Radic Biol Med       Date:  2013-06-21       Impact factor: 7.376

6.  Radicava/Edaravone Findings in Biomarkers From Amyotrophic Lateral Sclerosis (REFINE-ALS): Protocol and Study Design.

Authors:  James Berry; Benjamin Brooks; Angela Genge; Terry Heiman-Patterson; Stanley Appel; Michael Benatar; Robert Bowser; Merit Cudkowicz; Clifton Gooch; Jeremy Shefner; Jurjen Westra; Wendy Agnese; Charlotte Merrill; Sally Nelson; Stephen Apple
Journal:  Neurol Clin Pract       Date:  2021-08

7.  Bioenergetic markers in skin fibroblasts of sporadic amyotrophic lateral sclerosis and progressive lateral sclerosis patients.

Authors:  Kathryne Kirk; Chris Gennings; Jonathan C Hupf; Saba Tadesse; Marilena D'Aurelio; Hibiki Kawamata; Federica Valsecchi; Hiroshi Mitsumoto; Giovanni Manfredi
Journal:  Ann Neurol       Date:  2014-08-21       Impact factor: 10.422

Review 8.  Vitamin D as a potential therapy in amyotrophic lateral sclerosis.

Authors:  Alexandro Gianforcaro; Mazen J Hamadeh
Journal:  CNS Neurosci Ther       Date:  2014-02       Impact factor: 5.243

9.  The immune response in the CNS in Theiler's virus induced demyelinating disease switches from an early adaptive response to a chronic innate-like response.

Authors:  Francesca Gilli; Libin Li; Andrew R Pachner
Journal:  J Neurovirol       Date:  2015-08-11       Impact factor: 2.643

Review 10.  Mechanisms, models and biomarkers in amyotrophic lateral sclerosis.

Authors:  Martin R Turner; Robert Bowser; Lucie Bruijn; Luc Dupuis; Albert Ludolph; Michael McGrath; Giovanni Manfredi; Nicholas Maragakis; Robert G Miller; Seth L Pullman; Seward B Rutkove; Pamela J Shaw; Jeremy Shefner; Kenneth H Fischbeck
Journal:  Amyotroph Lateral Scler Frontotemporal Degener       Date:  2013-05       Impact factor: 4.092

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.